Literature DB >> 23199948

High performance of metal-on-metal bearings: a case report.

Regina P Woon1, Harlan C Amstutz.   

Abstract

There has been considerable initial success with the use of total hip and resurfacing metal-metal implants tempered by poor performance of certain bearing designs, specifically small and/or abnormal component orientation. With a growing number of reports relating to adverse local tissue reactions, the need to monitor ion levels is crucial. This report presents a case of an extremely active bilateral metal-metal implant patient who had severe arthritis of the left hip and was originally treated with a cementless metal-on-polyethylene surface replacement. This implant lasted 12~years and after complete wear through of the polyethylene, the prosthesis was converted to metal-on-metal total hip. The patient continued to cycle vigorously and engaged in downhill skiing. Eventually his contralateral hip developed arthritis and he underwent metal-on-metal surface arthroplasty. Since his last surgery 8~years ago, the patient has resumed his activities, cycling an average of 6,400 miles and skiing over 60~days a year. He has been followed clinically and radiographically for 23 years with ion levels measured serially.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23199948     DOI: 10.3113/jsoa.2012.0170

Source DB:  PubMed          Journal:  J Surg Orthop Adv        ISSN: 1548-825X


  2 in total

1.  Comparing return to sport activities after short metaphyseal femoral arthroplasty with resurfacing and big femoral head arthroplasties.

Authors:  Panagiotis K Karampinas; Eustratios G Papadelis; John A Vlamis; Hlias Basiliadis; Spiros G Pneumaticos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-01-03

2.  Implant failure in bilateral metal-on-metal hip resurfacing arthroplasties: a clinical and pathological study.

Authors:  Yoshinubo Uchihara; George Grammatopoulos; Mitsuru Munemoto; Gulraj Matharu; Yusuke Inagaki; Hemant Pandit; Yasuhito Tanaka; Nick A Athanasou
Journal:  J Mater Sci Mater Med       Date:  2018-03-07       Impact factor: 3.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.